Boniton en es it fr

Boniton Brand names, Boniton Analogs

Boniton Brand Names Mixture

  • No information avaliable

Boniton Chemical_Formula


Boniton RX_link

Boniton fda sheet

Boniton FDA

Boniton msds (material safety sheet)

Boniton MSDS

Boniton Synthesis Reference

No information avaliable

Boniton Molecular Weight

267.242 g/mol

Boniton Melting Point

235.5 oC

Boniton H2O Solubility

8230 mg/L

Boniton State


Boniton LogP


Boniton Dosage Forms


Boniton Indication

For controlling paroxysmal supraventricular tachycardia (PSVT). This drug can also be used diagnostically for stable, wide complex tachyardias of unknown type.

Boniton Pharmacology

Adenosine is an endogenous nucleoside occurring in all cells of the body and is not chemically related to other antiarrhythmic drugs. Adenosine is indicated for the conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). Adenosine is antagonized competitively by methylxanthines such as caffeine and theophylline, and potentiated by blockers of nucleoside transport such as dipyridamole. Adenosine is not blocked by atropine.

Boniton Absorption

No information avaliable

Boniton side effects and Toxicity

No information avaliable

Boniton Patient Information

No information avaliable

Boniton Organisms Affected

Humans and other mammals